From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers
NCT02863900
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
350
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
OTHER:
cohort of BC of each subtypes
Sponsor
Institut Claudius Regaud